RBS forecasts fits exactly with what Lee was saying at the AGM in terms of in the first year of international sales (from Nov 2013 to Nov 2014) really establishing themselves and forming a solid base (amongst leading surgeons)... from Nov 2014 to Nov 2016 it's explosive growth phase as they leverage off the data and surgical results and surgeon recommendations expected from these upcoming 12 months.
This is the jist of the company's strategy as I understood it although the question and answer were both a little unclear.
annual general meeting review, page-55
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.00 |
Change
-0.150(1.48%) |
Mkt cap ! $211.3M | |||
| Open | High | Low | Value | Volume |
| $10.26 | $10.35 | $9.80 | $295.8K | 29.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22 | $9.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.00 | 2758 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |